Optibiotix Health Plc (LON:OPTI) CEO Stephen O’Hara talks to DirectorsTalk about the recent share price movement. Stephen also talks about the potential for 39 RNS’s that could be announced over
OptiBiotix Health Plc (LON:OPTI) CEO Stephen O’Hara talks to DirectorsTalk about the listing of SkinBiotheraputics (LON:SBTX). Stephen explains the rationale behind the launch, what this could mean for OptiBiotix investors,
Optibiotix Health Plc (LON:OPTI) CEO Stephen O’Hara talks to DirectorsTalk about its European manufacturing, supply and profit sharing agreement with Sacco S.r.l. Stephen explains tells us more about the agreement
OptiBiotix Health plc (LON:OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announced in January that it has had two abstracts accepted for
Optibiotix Health Plc (LON:OPTI) CEO Stephen O’Hara talks to DirectorsTalk about a string of news since Christmas, Stephen gives us an overview of the company’s progress and plans for 2017.
OptiBiotix Health plc (LON:OPTI), a life sciences business developing products to tackle obesity, high cholesterol and diabetes, announces that it has entered into a joint development agreement (the “Agreement”) with
Optibiotix Health Plc (LON:OPTI) CEO Stephen OHara today spoke about an article published in the telegraph. The article refers to a major Lancet study which backed the safety of statins
OptiBiotix Health Plc (LON:OPTI) CEO Stephen O’Hara talks to DirectorsTalk about the recent Scientific and Commercial Update. Stephen talks us through the update providing more detail on both the scientific
Optibiotix Health’s Stephen O’Hara discusses the new appointment of Martin Hunt as Chairman at SkinBiotics, how this fits into their strategy and what it means for shareholders in this exclusive interview with DirectorsTalk
Optibiotix Health Plc (LON:OPTI) CEO Stephen O’Hara talks to DirectorsTalk about the appointment of a new chairman for its SkinBiotix division. Stephen explains the reasoning behind the decision, what this
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
